Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: The University of Wisconsin experience

Background We retrospectively examined the treatment efficacy and toxicity profile of intensity modulated radiotherapy (IMRT) plus concurrent weekly cisplatin chemotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck (HNSCC).